Literature DB >> 18841844

Air-kerma strength determination of a 169Yb high dose rate brachytherapy source.

J J VanDamme1, W S Culberson, L A DeWerd, J A Micka.   

Abstract

The increased demand for high dose rate (HDR) brachytherapy as an alternative to external beam radiotherapy has led to the introduction of a HDR brachytherapy isotope 169Yb. This source offers a dose rate similar to 192Ir HDR sources, at about one fourth the effective photon energy. This work presents the calibration of this source in terms of air-kerma strength, based on an adaptation of the current, National Institute of Standards and Technology traceable, in air measurement technique currently used for 192Ir HDR sources. Several additional measurement correction factors were required, including corrections for air scatter, air attenuation, and ion recombination. A new method 169Yb is introduced for determining the ion chamber calibration coefficient Nk(169Yb). An uncertainty analysis was also performed, indicating an overall measurement expanded uncertainty in the air-kerma strength (k=2) of 2.2%.

Mesh:

Substances:

Year:  2008        PMID: 18841844     DOI: 10.1118/1.2964094

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  3 in total

1.  Air kerma strength characterization of a GZP6 Cobalt-60 brachytherapy source.

Authors:  Mohammad Taghi Bahreyni Toossi; Mahdi Ghorbani; Ali Asghar Mowlavi; Mojtaba Taheri; Mohsen Layegh; Yasha Makhdoumi; Ali Soleimani Meigooni
Journal:  Rep Pract Oncol Radiother       Date:  2010-11-09

2.  Needle-free cervical cancer treatment using helical multishield intracavitary rotating shield brachytherapy with the 169 Yb Isotope.

Authors:  Karolyn M Hopfensperger; Quentin Adams; Yusung Kim; Xiaodong Wu; Weiyu Xu; Kaustubh Patwardhan; Bounnak Thammavong; Joseph Caster; Ryan T Flynn
Journal:  Med Phys       Date:  2020-03-13       Impact factor: 4.071

3.  Efficient 169 Yb high-dose-rate brachytherapy source production using reactivation.

Authors:  Ryan T Flynn; Quentin E Adams; Karolyn M Hopfensperger; Xiaodong Wu; Weiyu Xu; Yusung Kim
Journal:  Med Phys       Date:  2019-05-27       Impact factor: 4.071

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.